FIVE PRIME THERAPEUTICS INC — Form D

FIVE PRIME THERAPEUTICS INC of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2010-09-16. The offering totals $7.5M, of which $7.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
Brian Lee AtwoodDirectorMenlo Park, CA
Franklin P BergerDirectorSan Francisco, CA
James Lee BlairDirectorPrinceton, NJ
Brook Lee ByersDirectorMenlo Park, CA
Fred Lee CohenDirectorFort Worth, TX
Julia P GregoryDirectorDartmouth, A5
Mark P McDadeDirectorSan Francisco, CA
Julia P GregoryExecutive OfficerDartmouth, A5
Mark D McDadeDirectorMenlo Park, CA
Brian G AtwoodDirectorGaithersburg, MD
W. Michael Kavanaugh, M.D.Executive OfficerSouth San Francisco, CA
R. Lee DouglasDirectorSouth San Francisco, CA
Fred E Cohen, M.D., D.Phil.DirectorSouth San Francisco, CA
Franklin M Berger, CFADirectorSouth San Francisco, CA
Julie L Hambleton, M.D.Executive OfficerSouth San Francisco, CA
Francis W SarenaExecutive OfficerSouth San Francisco, CA
Peder K Jensen, M.D.DirectorSouth San Francisco, CA
Aron M KnickerbockerDirectorSouth San Francisco, CA
Aron M KnickerbockerExecutive OfficerSouth San Francisco, CA
Lewis T WilliamsDirectorSouth San Francisco, CA
Lewis T WilliamsExecutive OfficerSouth San Francisco, CA
Robert Lee DouglasDirectorThe Woodlands, TX
Marc Michael BelskyExecutive OfficerSouth San Francisco, CA
Mark T McDadeDirectorSouth San Francisco, CA
Lauretta Michael CesarioExecutive OfficerSouth San Francisco, CA

Other filings by this issuer (2)

FiledFormOfferingSold
2014-03-26D$21.0M$21.0M
2012-04-20D$10.0M$10.0M

More